Surgical Strategies and Outcomes after Induction Therapy for Non-Small Cell Lung Cancer

被引：5

作者：

Burfeind, William R., Jr. ^{[1
]}

Harpole, David H., Jr. ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA

来源：

SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY | 2005年 / 17卷 / 03期

关键词：

lung cancer; neoadjuvant therapy; induction therapy;

D O I：

10.1053/j.semtcvs.2005.06.015

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Surgery as the sole therapy for locally advanced non-small cell lung cancer (NSCLC) is usually not curative. Adjuvant chemotherapy has been evaluated by several randomized Phase III trials and found to confer a survival benefit over surgery alone for stage IB-IIIA NSCLC. Induction therapy applies a cytoreductive and systemic therapy before definitive locoregional therapy. Theoretical advantages include improved diffusion of chemotherapy agents into the tumor, improved compliance, and a higher complete resection rate. Results from multiple Phase II and III studies have been encouraging, but the role of surgery after induction therapy remains inconclusively defined. Randomized trials are underway to better define the role of induction therapy, and enrollment of patients into such trials should be encouraged. © 2005 Elsevier Inc. All rights reserved.

引用

页码：186 / 190

页数：5

共 27 条

[1] CONCURRENT CISPLATIN/ETOPOSIDE PLUS CHEST RADIOTHERAPY FOLLOWED BY SURGERY FOR STAGES IIIA(N2) AND IIIB NON-SMALL-CELL LUNG-CANCER - MATURE RESULTS OF SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY-8805 [J].

ALBAIN, KS ;

RUSCH, VW ;

CROWLEY, JJ ;

RICE, TW ;

TURRISI, AT ;

WEICK, JK ;

LONCHYNA, VA ;

PRESANT, CA ;

MCKENNA, RJ ;

GANDARA, DR ;

FOSMIRE, H ;

TAYLOR, SA ;

STELZER, KJ ;

BEASLEY, KR ;

LIVINGSTON, RB .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1880-1892

[2]

ALBAIN KS, 2003, P AN M AM SOC CLIN, V22, P621

[3] Mediastinal lymph node clearance after docetaxel-cisplatin Neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer:: A multicenter phase II trial [J].

Betticher, DC ;

Schmitz, SFH ;

Tötsch, M ;

Hansen, E ;

Joss, C ;

von Briel, C ;

Schmid, RA ;

Pless, M ;

Habicht, J ;

Roth, AD ;

Spiliopoulos, A ;

Stahel, R ;

Weder, W ;

Stupp, R ;

Egli, F ;

Furrer, M ;

Honegger, H ;

Wernli, M ;

Cerny, T ;

Ris, HB .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) :1752-1759

[4] Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival [J].

Bueno, R ;

Richards, WG ;

Swanson, SJ ;

Jaklitsch, MT ;

Lukanich, JM ;

Mentzer, SJ ;

Sugarbaker, DJ .

ANNALS OF THORACIC SURGERY, 2000, 70 (06) :1826-1831

[5]

Burfeind WR, 2005, ANN THORAC IN PRESS

[6] Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer [J].

Depierre, A ;

Milleron, B ;

Moro-Sibilot, D ;

Chevret, S ;

Quoix, E ;

Lebeau, B ;

Braun, D ;

Breton, JL ;

Lemarié, E ;

Gouva, S ;

Paillot, N ;

Bréchot, JM ;

Janicot, H ;

Lebas, FX ;

Terrioux, P ;

Clavier, J ;

Foucher, P ;

Monchâtre, M ;

Coëtmeur, D ;

Level, MC ;

Leclerc, P ;

Blanchon, F ;

Rodier, JM ;

Thiberville, L ;

Villeneuve, A ;

Westeel, V ;

Chastang, C .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :247-253

[7] Sleeve lobectomy versus pneumonectomy for lung cancer:: A comparative analysis of survival and sites or recurrences [J].

Deslauriers, J ;

Grégoire, J ;

Jacques, LF ;

Piraux, M ;

Liu, GJ ;

Lacasse, Y .

ANNALS OF THORACIC SURGERY, 2004, 77 (04) :1152-1156

[8] Cancer statistics, 2005 [J].

Jemal, A ;

Murray, T ;

Ward, E ;

Samuels, A ;

Tiwari, RC ;

Ghafoor, A ;

Feuer, EJ ;

Thun, MJ .

CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30

[9] A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer. [J].

Keller, SM ;

Adak, S ;

Wagner, H ;

Herskovic, A ;

Komaki, R ;

Brooks, BJ ;

Perry, MC ;

Livingston, RB ;

Johnson, DH .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (17) :1217-1222

[10] Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer [J].

Le Chevalier, T ;

Arriagada, R ;

Le Péchoux, C ;

Grunenwald, D ;

Dunant, A ;

Pignon, JP ;

Tarayre, M ;

Abratt, R ;

Arriagada, R ;

Bergman, B ;

Gralla, R ;

Grunenwald, D ;

Le Chevalier, T ;

Orlowski, T ;

Papadakis, E ;

Pinel, MIS ;

Araujo, C ;

Della Torre, H ;

de Solchaga, MM ;

Abdi, E ;

Blum, R ;

Ball, D ;

Basser, R ;

De Boer, R ;

Bishop, J ;

Brigham, B ;

Davis, S ;

Fox, D ;

Richardson, G ;

Wyld, D ;

Pirker, R ;

Humblet, Y ;

Delaunois, L ;

Van Meerbeeck, JP ;

Germonpre, P ;

Vansteenkiste, J ;

Nackaerts, K ;

Pinel, MIS ;

Vauthier, G ;

Younes, RN ;

Arriagada, R ;

Baeza, R ;

Carvajal, P ;

Kleinman, S ;

Orlandi, L ;

Castro, C ;

Godoy, J ;

Kosatova, K ;

Gaafar, R ;

Azarian, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :351-360

← 1 2 3 →